These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31204507)

  • 1. Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study.
    Heled E; Aloni R; Achiron A
    Appl Neuropsychol Adult; 2021; 28(2):210-219. PubMed ID: 31204507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive trajectories in relapsing-remitting multiple sclerosis: A longitudinal 6-year study.
    Damasceno A; Pimentel-Silva LR; Damasceno BP; Cendes F
    Mult Scler; 2020 Nov; 26(13):1740-1751. PubMed ID: 31603042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability.
    Has Silemek AC; Fischer L; Pöttgen J; Penner IK; Engel AK; Heesen C; Gold SM; Stellmann JP
    Neuroimage Clin; 2020; 25():102177. PubMed ID: 32014828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis.
    Hechenberger S; Helmlinger B; Ropele S; Pirpamer L; Bachmaier G; Damulina A; Pichler A; Khalil M; Enzinger C; Pinter D
    Mult Scler Relat Disord; 2022 Jan; 57():103353. PubMed ID: 35158430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
    Wybrecht D; Reuter F; Pariollaud F; Zaaraoui W; Le Troter A; Rico A; Confort-Gouny S; Soulier E; Guye M; Maarouf A; Ranjeva JP; Pelletier J; Audoin B
    PLoS One; 2017; 12(11):e0184650. PubMed ID: 29149177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
    Andravizou A; Siokas V; Artemiadis A; Bakirtzis C; Aloizou AM; Grigoriadis N; Kosmidis MH; Nasios G; Messinis L; Hadjigeorgiou G; Dardiotis E; Peristeri E
    Neurol Res; 2020 Jul; 42(7):575-586. PubMed ID: 32427076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Picconi O; Cilia S; Cottone S; Grimaldi LM;
    Qual Life Res; 2012 Sep; 21(7):1111-21. PubMed ID: 21953022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
    Yam C; Merlo D; Stankovich J; Darby D; Gresle M; Kalincik T; Kilpatrick TJ; Lechner-Scott J; Taylor B; Barnett M; Butzkueven H; van der Walt A
    Mult Scler Relat Disord; 2020 Aug; 43():102212. PubMed ID: 32474286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.